drug interaction(s) of warfarin with antiplatelet agents
Jump to navigation
Jump to search
Indications
- aspirin & clopidogrel are recommended for patients after acute myocardial infarction (MI), & many patients with acute MI also have indications for warfarin
- patients with atrial fibrillation*
- prophylaxis for venous thromboembolism
* addition of aspirin to warfarin may not reduce risk of myocardial infarction in patients with stable coronary artery disease[3] - no data after cororary revascularization
Drug interactions
- combination of warfarin plus antiplatelet agent associated with substantial risk of serious bleeding
- adjusted relative risks for fatal & nonfatal bleeding relative to aspirin alone:
- 1.23 for warfarin alone
- 1.33 for clopidogrel alone
- 1.47 for aspirin plus clopidogrel
- 1.84 for aspirin plus warfarin
- ref[3] gives a much higher relative risk (7.3)
- 3.52 for clopidogrel plus a vitamin K antagonist
- 4.05 for aspirin plus clopidogrel plus warfarin
- adjusted number needed to harm is 12.5 (aspirin plus clopidogrel plus warfarin)[2]
More general terms
References
- ↑ Rogacka R et al, Dual antiplatelet therapy after percutaneous coronary intervention with stent implantation in patients taking chronic oral anticoagulation. J Am Coll Cardiol Intv 2008, 1:56 PMID: https://www.ncbi.nlm.nih.gov/pubmed/19393145
Johnson SG et al, Outcomes associaed with combined antiplatelet and anticoagulant therapy. Chest 2008, 133:948 PMID: https://www.ncbi.nlm.nih.gov/pubmed/18198244 - ↑ 2.0 2.1 Sorensen R et al. Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: A retrospective analysis of nationwide registry data. Lancet 2009 Dec 12; 374:1967. PMID: https://www.ncbi.nlm.nih.gov/pubmed/20006130
- ↑ 3.0 3.1 3.2 Hamon M et al. Incidence, source, determinants, and prognostic impact of major bleeding in outpatients with stable coronary artery disease. J Am Coll Cardiol 2014 Oct 7; 64:1430. PMID: https://www.ncbi.nlm.nih.gov/pubmed/25277612
Dauerman HL. Reconsidering the necessity of aspirin in stable coronary artery disease. J Am Coll Cardiol 2014 Oct 7; 64:1437 PMID: https://www.ncbi.nlm.nih.gov/pubmed/25277613